SEMA4D was also highly expressed in regulatory T cells (Tregs) and exhausted CD8+ T cells (CD8+ Tex) in NSCLC, CRC, HNSC, and LIHC, indicating that SEMA4D may suppress the immune effect of T cells. This evidence concerns the gene CD8A and colorectal carcinoma.